🔖
Bu Makaleye Atıf Yap
YILDIRIM, H., DURAN, F. Y., ŞEN, E. M. (2022). Tigesiklinin Daha Az Bilinen Bir Yan Etkisi: Hipofibrinojenemi. Turkish Journal of Hematology, Cilt: 35 - Sayı: 1, 95–96. https://ajindex.com/articles/606725
Dergiler / Turkish Journal of Hematology / 2018 / Cilt: 35 - Sayı: 1
Tigesiklinin Daha Az Bilinen Bir Yan Etkisi: Hipofibrinojenemi
- Sayfa
- 95–96
- Yayın Tarihi
- 2022-11-05
- DOI
- —
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗Kaynakça (7)
- Sabanis N, Paschou E, Gavriilaki E, Kalaitzoglou A, Vasileiou S. Hypofibrinogenemia induced by tigecycline: a potentially life-threatening coagulation disorder. Infect Dis (Lond) 2015;47:743-746
- Zhang Q, Zhou S, Zhou J. Tigecycline treatment causes a decrease in fibrinogen levels. Antimicrob Agents Chemother 2015;59:1650-1655
- Martis N, Chirio D, Queyrel-Moranne V, Zenut MC, Rocher F, Fuzibet JG. Tocilizumab-induced hypofibrinogenemia: a report of 7 cases. Joint Bone Spine 2017;84:369-370
- Zhou HB. Hypofibrinogenemia caused by hemocoagulase after colon polyps excision. Am J Case Rep 2017;18:291-293
- Rossitto G, Piano S, Rosi S, Simioni P, Angeli P. Life-threatening coagulopathy and hypofibrinogenaemia induced by tigecycline in a patient with advanced liver cirrhosis. Eur J Gastroenterol Hepatol 2014;26:681-684
- Routsi C, Kokkoris S, Douka E, Ekonomidou F, Karaiskos I, Giamarellou H. High-dose tigecycline-associated alterations in coagulation parameters in critically ill patients with severe infections. Int J Antimicrob Agents 2015;45:90-93
- Pieringer H, Schmekal B, Biesenbach G, Pohanka E. Severe coagulation disorder with hypofibrinogenemia associated with the use of tigecycline. Ann Hematol 2010;89:1063-1064.